BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 10652433)

  • 21. p190RhoGAP can act to inhibit PDGF-induced gliomas in mice: a putative tumor suppressor encoded on human chromosome 19q13.3.
    Wolf RM; Draghi N; Liang X; Dai C; Uhrbom L; Eklöf C; Westermark B; Holland EC; Resh MD
    Genes Dev; 2003 Feb; 17(4):476-87. PubMed ID: 12600941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation.
    Hermansson M; Nistér M; Betsholtz C; Heldin CH; Westermark B; Funa K
    Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7748-52. PubMed ID: 2845420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic antiproliferative effect of imatinib and adriamycin in platelet-derived growth factor receptor-expressing osteosarcoma cells.
    Yamaguchi SI; Ueki A; Sugihara E; Onishi N; Yaguchi T; Kawakami Y; Horiuchi K; Morioka H; Matsumoto M; Nakamura M; Muto A; Toyama Y; Saya H; Shimizu T
    Cancer Sci; 2015 Jul; 106(7):875-82. PubMed ID: 25940371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus.
    Uhrbom L; Hesselager G; Nistér M; Westermark B
    Cancer Res; 1998 Dec; 58(23):5275-9. PubMed ID: 9850047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imatinib as a key inhibitor of the platelet-derived growth factor receptor mediated expression of cell surface heparan sulfate proteoglycans and functional properties of breast cancer cells.
    Malavaki CJ; Roussidis AE; Gialeli C; Kletsas D; Tsegenidis T; Theocharis AD; Tzanakakis GN; Karamanos NK
    FEBS J; 2013 May; 280(10):2477-89. PubMed ID: 23374223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet-derived growth factor receptors: a therapeutic target in solid tumors.
    George D
    Semin Oncol; 2001 Oct; 28(5 Suppl 17):27-33. PubMed ID: 11740804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of platelet-derived growth factor signalling induces autophagy in malignant glioma cells.
    Takeuchi H; Kanzawa T; Kondo Y; Kondo S
    Br J Cancer; 2004 Mar; 90(5):1069-75. PubMed ID: 14997209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice.
    Lev DC; Kim SJ; Onn A; Stone V; Nam DH; Yazici S; Fidler IJ; Price JE
    Clin Cancer Res; 2005 Jan; 11(1):306-14. PubMed ID: 15671560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity.
    Basciani S; Brama M; Mariani S; De Luca G; Arizzi M; Vesci L; Pisano C; Dolci S; Spera G; Gnessi L
    Cancer Res; 2005 Mar; 65(5):1897-903. PubMed ID: 15753388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of platelet-derived growth factor (PDGF)-B and PDGF-receptor β is associated with lymphatic metastasis in human gastric carcinoma.
    Kodama M; Kitadai Y; Sumida T; Ohnishi M; Ohara E; Tanaka M; Shinagawa K; Tanaka S; Yasui W; Chayama K
    Cancer Sci; 2010 Sep; 101(9):1984-9. PubMed ID: 20624165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet-derived growth factor-BB: a stimulus for cytokine production by orbital fibroblasts in Graves' ophthalmopathy.
    van Steensel L; Paridaens D; Dingjan GM; van Daele PL; van Hagen PM; Kuijpers RW; van den Bosch WA; Drexhage HA; Hooijkaas H; Dik WA
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1002-7. PubMed ID: 19797221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor).
    Heinrich MC; McArthur GA; Demetri GD; Joensuu H; Bono P; Herrmann R; Hirte H; Cresta S; Koslin DB; Corless CL; Dirnhofer S; van Oosterom AT; Nikolova Z; Dimitrijevic S; Fletcher JA
    J Clin Oncol; 2006 Mar; 24(7):1195-203. PubMed ID: 16505440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension.
    Perros F; Montani D; Dorfmüller P; Durand-Gasselin I; Tcherakian C; Le Pavec J; Mazmanian M; Fadel E; Mussot S; Mercier O; Hervé P; Emilie D; Eddahibi S; Simonneau G; Souza R; Humbert M
    Am J Respir Crit Care Med; 2008 Jul; 178(1):81-8. PubMed ID: 18420966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PDGF BB induces VEGF secretion in ovarian cancer.
    Matei D; Kelich S; Cao L; Menning N; Emerson RE; Rao J; Jeng MH; Sledge GW
    Cancer Biol Ther; 2007 Dec; 6(12):1951-9. PubMed ID: 18075302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of the platelet-derived growth factor-receptor enhances survival of murine bone endothelial cells.
    Langley RR; Fan D; Tsan RZ; Rebhun R; He J; Kim SJ; Fidler IJ
    Cancer Res; 2004 Jun; 64(11):3727-30. PubMed ID: 15172974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imatinib mesylate inhibits platelet-derived growth factor activity and increases chemosensitivity in feline vaccine-associated sarcoma.
    Katayama R; Huelsmeyer MK; Marr AK; Kurzman ID; Thamm DH; Vail DM
    Cancer Chemother Pharmacol; 2004 Jul; 54(1):25-33. PubMed ID: 15108021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of platelet-derived growth factor (PDGF) in the epididymis and analysis of the epididymal development in PDGF-A, PDGF-B, and PDGF receptor beta deficient mice.
    Basciani S; Mariani S; Arizzi M; Brama M; Ricci A; Betsholtz C; Bondjers C; Ricci G; Catizone A; Galdieri M; Spera G; Gnessi L
    Biol Reprod; 2004 Jan; 70(1):168-77. PubMed ID: 14522834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
    Major TC; Keiser JA
    J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting PDGF receptors in cancer--rationales and proof of concept clinical trials.
    George D
    Adv Exp Med Biol; 2003; 532():141-51. PubMed ID: 12908555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling.
    Hasumi Y; Kłosowska-Wardega A; Furuhashi M; Ostman A; Heldin CH; Hellberg C
    Int J Cancer; 2007 Dec; 121(12):2606-14. PubMed ID: 17691110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.